Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 20/20 | 0.66 |
| ▸ | SLC6A3 | Q01959 | 13/20 | 0.66 |
| ▸ | SLC6A4 | P31645 | 11/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3986831 | 1.00 | SLC6A2 (0.66) | SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL3959547 | 1.00 | SLC6A2 (0.66) | SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL3992609 | 1.00 | SLC6A2 (0.66) | SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL3951816 | 1.00 | SLC6A2 (0.66) | SLC6A2SLC6A3SLC6A4 | |
| Hydrochloric Acid SCHEMBL3952536 | 0.99 | SLC6A2 (0.67) | SLC6A2SLC6A3SLC6A4 | |
| Hydrochloric Acid SCHEMBL3956450 | 0.99 | SLC6A2 (0.67) | SLC6A2SLC6A3SLC6A4 | |
| Hydrochloric Acid SCHEMBL6371688 | 0.99 | SLC6A2 (0.67) | SLC6A2SLC6A3SLC6A4 | |
| Hydrochloric Acid SCHEMBL3956710 | 0.99 | SLC6A2 (0.67) | SLC6A2SLC6A3SLC6A4 | |
| Hydrochloric Acid SCHEMBL3956074 | 0.99 | SLC6A2 (0.67) | SLC6A2SLC6A3SLC6A4 | |
| SCHEMBL3960407 | 0.93 | SLC6A2 (0.72) | SLC6A2SLC6A3SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1673084-A1 | 1-2' (1,4'-BIPERIDIN-1'-YL)-1-(PHENYL)-ETHYLCYCLOHEXANOL DERIVATIVES AS MONOAMINE REUPTAKE MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS | Wyeth (US) | 2006-06-28 | — | — | EP | disclosed |
| WO-2005037279-A1 | 1- 2’ (1, 4’-BIPERIDIN-1’-YL)-1- (PHENYL) -ETHYL CYCLOHEXANOL DERIVATIVES AS MONOAMINE REUPTAKE MODULATORS FOR THE TREATMENT OF VISOMOTOR SYMPTOMS | WYETH (US) | 2005-04-28 | — | — | WO | disclosed |